Rigel(RIGL) - 2025 Q4 - Earnings Call Transcript

Rigel Pharmaceuticals (NasdaqGS:RIGL) Q4 2025 Earnings call March 03, 2026 04:30 PM ET Company ParticipantsAshley Aloupis - Equity Research AssociateDavid Santos - Chief Commercial OfficerDean Schorno - CFOJoe Pantginis - Managing Director of Equity ResearchLisa Rojkjaer - EVP and Chief Medical OfficerRaul Rodriguez - President and CEORaymond Furey - EVP, General Counsel and Corporate SecretaryConference Call ParticipantsFarzin Haque - SVP and Biotechnology Equity Research AnalystKristen Kluska - Director a ...